The fat mass and obesity-associated (FTO) gene is the strongest common genetic determinant of body mass index (BMI), and physical activity (PA) has been proposed to attenuate its effect. Evidence published since 2021 has not been systematically synthesized. This systematic review summarizes recent human evidence (January 2021 to December 2026) on the interaction between FTO variants and PA on BMI and related adiposity outcomes. PubMed was searched on 2 September 2026 using a sensitive three-block strategy combining FTO, PA, and BMI terms. Eligible studies were human observational or interventional studies that formally tested an FTO × PA interaction on BMI or adiposity. Screening, data extraction, and quality assessment with a simplified Newcastle-Ottawa scale were performed, and findings were synthesized qualitatively following PRISMA 2020. Of 92 records identified, 18 studies met the eligibility criteria (sample sizes 16-20,906; eight cross-sectional, three cohort, two case-control, and five interventional studies). Eleven studies (61%) reported a significant attenuating interaction, whereby higher PA or structured exercise reduced the effect of FTO risk alleles on adiposity (for example, a 47% attenuation in Danish adults and an approximately two-fold lower obesity risk in physically active Korean risk-allele carriers), whereas seven studies, mostly small or selected samples, reported null interactions. In conclusion, recent evidence generally supports that higher PA attenuates FTO-associated adiposity, but heterogeneity in PA measurement, genotyped variants, and populations, together with a preponderance of cross-sectional designs, tempers certainty (low-to-moderate on a GRADE-style assessment).
Research Article
Open Access